FIELD: medicine, biochemical and genetic diagnostics.
SUBSTANCE: the present innovation deals with detecting genetic markers in human biological liquid. So, in a patient's saliva due PCR technique it is necessary to determine the frequency of alleles and genotypes of DRD2 and DAT genes and at detecting the increase of genotype A1/A2 of DRD2 gene and allele 440 of 440-440 genotypes and 440-480 of DAT gene in males and females against the standard one should predict the predisposition to addictive disorders in the form of alcoholism and co-addiction. The, additionally, one should carry out psychological testing and according to correlation of increased mentioned genetic markers against detected psychopathological peculiarities it is important to establish the predisposition to either alcoholism or co-addiction.
EFFECT: higher efficiency.
1 cl, 5 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE INDIVIDUAL RISK OF DEVELOPMENT OF DISORDERS OF ADDITIVE CHARACTER | 2016 |
|
RU2621171C1 |
| METHOD OF DETERMINING THE RISK OF FORMING ADDITIVE BEHAVIOR | 2016 |
|
RU2621278C1 |
| MULTIPLEX SET OF MARKERS AS TOOL FOR DEVELOPING GENETIC TESTING OF SUSCEPTIBILITY TO SCHIZOPHRENIA, ALCOHOLISM AND CONNECTION WITH PERSONALITY TRAITS IN YOUNG PEOPLE AND MENTAL ABILITIES IN OLD AGE | 2022 |
|
RU2819816C1 |
| METHOD OF PREVENTION AND/OR TREATMENT OF PSYCHOACTIVE SUBSTANCE DEPENDENCE | 2008 |
|
RU2402974C2 |
| METHOD FOR INTEGRATED ASSESSMENT OF GENETIC PREDISPOSITION TO DEVELOPMENT OF PSYCHOACTIVE SUBSTANCE ABUSE | 2012 |
|
RU2505820C1 |
| METHOD OF PROFESSIONAL SELECTION OF EMPLOYEES OF POWER DEPARTMENTS AND PERSONS WHOSE ACTIVITIES ARE ASSOCIATED WITH HIGH RISK TO LIFE AND HEALTH, FOR EFFECTIVE PERFORMANCE OF SERVICE ACTIVITIES IN EXTREME CONDITIONS | 2019 |
|
RU2741342C1 |
| METHOD FOR PREDICTION OF COMORBID COURSE OF AFFECTIVE DISORDERS AND ALCOHOLISM BASED ON DETERMINATION OF BLOOD SERUM PROTEINS | 2021 |
|
RU2767699C1 |
| METHOD FOR EVALUATING PREDISPOSITION TO PRIMARY PATHOLOGICAL ATTRACTION TO PSYCHOACTIVE DRUGS IN TEENAGERS | 2003 |
|
RU2269937C2 |
| METHOD FOR PREDICTING THE DEGREE OF RISK OF EXTRAPYRAMID SIDE EFFECTS DURING THE BACKGROUND OF HALOPERIDOL THERAPY IN PATIENTS WITH SCHIZOPHRENIC SPECTRUM DISORDERS | 2021 |
|
RU2771180C1 |
| METHOD FOR ANALYSING GENETIC POLYMORPHISM FOR DETERMINING DISPOSITION TO SCHIZOPHRENIA AND ALCOHOLISM | 2012 |
|
RU2565036C2 |
